SEC Form 4 · accession 0001140361-18-009197
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bill Roeschlein
Officer — Chief Financial Officer
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2018 | A | 60,000 | $0.00 | A | 60,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.3501 | Feb 15, 2018 | A | 60,000 | A | — | Feb 14, 2028 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on February 8, 2021.
- F2The option grant vests monthly over 4 years from the date of grant.